2.4.1.9 Html 106 265 1 false 41 0 false 6 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.BioPharmX.com/role/DocumentDocumentAndEntityInformation Document and Entity Information true false R2.htm 00100 - Statement - Consolidated Balance Sheets Sheet http://www.BioPharmX.com/role/StatementConsolidatedBalanceSheets Consolidated Balance Sheets false false R3.htm 00105 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.BioPharmX.com/role/StatementConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) false false R4.htm 00200 - Statement - Consolidated Statements of Operations and Comprehensive Loss Sheet http://www.BioPharmX.com/role/StatementConsolidatedStatementsOfOperationsAndComprehensiveLoss Consolidated Statements of Operations and Comprehensive Loss false false R5.htm 00300 - Statement - Consolidated Statements of Convertible Redeemable Preferred Stock and Stockholders' Deficit Sheet http://www.BioPharmX.com/role/StatementConsolidatedStatementsOfConvertibleRedeemablePreferredStockAndStockholdersDeficit Consolidated Statements of Convertible Redeemable Preferred Stock and Stockholders' Deficit false false R6.htm 00400 - Statement - Consolidated Statements of Cash Flows Sheet http://www.BioPharmX.com/role/StatementConsolidatedStatementsOfCashFlows Consolidated Statements of Cash Flows false false R7.htm 10101 - Disclosure - Formation and Business of the Company Sheet http://www.BioPharmX.com/role/DisclosureFormationAndBusinessOfCompany Formation and Business of the Company false false R8.htm 10201 - Disclosure - Summary Of Significant Accounting Policies Sheet http://www.BioPharmX.com/role/DisclosureSummaryOfSignificantAccountingPolicies Summary Of Significant Accounting Policies false false R9.htm 10301 - Disclosure - Going Concern Considerations and Management's Plan Sheet http://www.BioPharmX.com/role/DisclosureGoingConcernConsiderationsAndManagementSPlan Going Concern Considerations and Management's Plan false false R10.htm 10401 - Disclosure - Fair Value Measurements Sheet http://www.BioPharmX.com/role/DisclosureFairValueMeasurements Fair Value Measurements false false R11.htm 10501 - Disclosure - Inventory Sheet http://www.BioPharmX.com/role/DisclosureInventory Inventory false false R12.htm 10601 - Disclosure - Property and Equipment Sheet http://www.BioPharmX.com/role/DisclosurePropertyAndEquipment Property and Equipment false false R13.htm 10701 - Disclosure - Restricted Cash Sheet http://www.BioPharmX.com/role/DisclosureRestrictedCash Restricted Cash false false R14.htm 10801 - Disclosure - Accrued Liabilities Sheet http://www.BioPharmX.com/role/DisclosureAccruedLiabilities Accrued Liabilities false false R15.htm 10901 - Disclosure - Related Party Payables Sheet http://www.BioPharmX.com/role/DisclosureRelatedPartyPayables Related Party Payables false false R16.htm 11001 - Disclosure - Long-Term Obligations Sheet http://www.BioPharmX.com/role/DisclosureLongTermObligations Long-Term Obligations false false R17.htm 11101 - Disclosure - Commitments and Contigencies Sheet http://www.BioPharmX.com/role/DisclosureCommitmentsAndContigencies Commitments and Contigencies false false R18.htm 11201 - Disclosure - Convertible Redeemable Preferred Stock and Stockholders' Equity Sheet http://www.BioPharmX.com/role/DisclosureConvertibleRedeemablePreferredStockAndStockholdersEquity Convertible Redeemable Preferred Stock and Stockholders' Equity false false R19.htm 11301 - Disclosure - Stock-Based Compensation Sheet http://www.BioPharmX.com/role/DisclosureStockBasedCompensation Stock-Based Compensation false false R20.htm 11401 - Disclosure - Employee Benefit Plan Sheet http://www.BioPharmX.com/role/DisclosureEmployeeBenefitPlan Employee Benefit Plan false false R21.htm 11501 - Disclosure - Income Taxes Sheet http://www.BioPharmX.com/role/DisclosureIncomeTaxes Income Taxes false false R22.htm 11601 - Disclosure - Subsequent Events Sheet http://www.BioPharmX.com/role/DisclosureSubsequentEvents Subsequent Events false false R23.htm 20202 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.BioPharmX.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) false false R24.htm 30203 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.BioPharmX.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) false false R25.htm 30503 - Disclosure - Inventory (Tables) Sheet http://www.BioPharmX.com/role/DisclosureInventoryTables Inventory (Tables) false false R26.htm 30603 - Disclosure - Property and Equipment (Tables) Sheet http://www.BioPharmX.com/role/DisclosurePropertyAndEquipmentTables Property and Equipment (Tables) false false R27.htm 30803 - Disclosure - Accrued Liabilities (Tables) Sheet http://www.BioPharmX.com/role/DisclosureAccruedLiabilitiesTables Accrued Liabilities (Tables) false false R28.htm 31103 - Disclosure - Commitments and Contigencies (Tables) Sheet http://www.BioPharmX.com/role/DisclosureCommitmentsAndContigenciesTables Commitments and Contigencies (Tables) false false R29.htm 31203 - Disclosure - Convertible Redeemable Preferred Stock and Stockholders' Equity (Tables) Sheet http://www.BioPharmX.com/role/DisclosureConvertibleRedeemablePreferredStockAndStockholdersEquityTables Convertible Redeemable Preferred Stock and Stockholders' Equity (Tables) false false R30.htm 31303 - Disclosure - Stock-Based Compensation (Tables) Sheet http://www.BioPharmX.com/role/DisclosureStockBasedCompensationTables Stock-Based Compensation (Tables) false false R31.htm 40101 - Disclosure - Formation and Business of the Company (Details) Sheet http://www.BioPharmX.com/role/DisclosureFormationAndBusinessOfCompanyDetails Formation and Business of the Company (Details) false false R32.htm 40201 - Disclosure - Summary Of Significant Accounting Policies (Details) Sheet http://www.BioPharmX.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails Summary Of Significant Accounting Policies (Details) false false R33.htm 40202 - Disclosure - Summary Of Significant Accounting Policies (Details 2) Sheet http://www.BioPharmX.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails2 Summary Of Significant Accounting Policies (Details 2) false false R34.htm 40301 - Disclosure - Going Concern Considerations and Management's Plan (Details) Sheet http://www.BioPharmX.com/role/DisclosureGoingConcernConsiderationsAndManagementSPlanDetails Going Concern Considerations and Management's Plan (Details) false false R35.htm 40501 - Disclosure - Inventory (Details) Sheet http://www.BioPharmX.com/role/DisclosureInventoryDetails Inventory (Details) false false R36.htm 40601 - Disclosure - Property and Equipment (Details) Sheet http://www.BioPharmX.com/role/DisclosurePropertyAndEquipmentDetails Property and Equipment (Details) false false R37.htm 40701 - Disclosure - Restricted Cash (Details) Sheet http://www.BioPharmX.com/role/DisclosureRestrictedCashDetails Restricted Cash (Details) false false R38.htm 40801 - Disclosure - Accrued Liabilities (Details) Sheet http://www.BioPharmX.com/role/DisclosureAccruedLiabilitiesDetails Accrued Liabilities (Details) false false R39.htm 40901 - Disclosure - Related Party Payables (Details) Sheet http://www.BioPharmX.com/role/DisclosureRelatedPartyPayablesDetails Related Party Payables (Details) false false R40.htm 41001 - Disclosure - Long-Term Obligations (Details) Sheet http://www.BioPharmX.com/role/DisclosureLongTermObligationsDetails Long-Term Obligations (Details) false false R41.htm 41002 - Disclosure - Long-Term Obligations (Details 2) Sheet http://www.BioPharmX.com/role/DisclosureLongTermObligationsDetails2 Long-Term Obligations (Details 2) false false R42.htm 41003 - Disclosure - Long-Term Obligations (Details 3) Sheet http://www.BioPharmX.com/role/DisclosureLongTermObligationsDetails3 Long-Term Obligations (Details 3) false false R43.htm 41101 - Disclosure - Commitments and Contigencies (Details) Sheet http://www.BioPharmX.com/role/DisclosureCommitmentsAndContigenciesDetails Commitments and Contigencies (Details) false false R44.htm 41102 - Disclosure - Commitments and Contigencies (Details 2) Sheet http://www.BioPharmX.com/role/DisclosureCommitmentsAndContigenciesDetails2 Commitments and Contigencies (Details 2) false false R45.htm 41103 - Disclosure - Commitments and Contigencies (Details 3) Sheet http://www.BioPharmX.com/role/DisclosureCommitmentsAndContigenciesDetails3 Commitments and Contigencies (Details 3) false false R46.htm 41201 - Disclosure - Convertible Redeemable Preferred Stock and Stockholders' Equity (Details) Sheet http://www.BioPharmX.com/role/DisclosureConvertibleRedeemablePreferredStockAndStockholdersEquityDetails Convertible Redeemable Preferred Stock and Stockholders' Equity (Details) false false R47.htm 41202 - Disclosure - Convertible Redeemable Preferred Stock and Stockholders' Equity (Details 2) Sheet http://www.BioPharmX.com/role/DisclosureConvertibleRedeemablePreferredStockAndStockholdersEquityDetails2 Convertible Redeemable Preferred Stock and Stockholders' Equity (Details 2) false false R48.htm 41203 - Disclosure - Convertible Redeemable Preferred Stock and Stockholders' Equity (Details 3) Sheet http://www.BioPharmX.com/role/DisclosureConvertibleRedeemablePreferredStockAndStockholdersEquityDetails3 Convertible Redeemable Preferred Stock and Stockholders' Equity (Details 3) false false R49.htm 41204 - Disclosure - Convertible Redeemable Preferred Stock and Stockholders' Equity (Details 4) Sheet http://www.BioPharmX.com/role/DisclosureConvertibleRedeemablePreferredStockAndStockholdersEquityDetails4 Convertible Redeemable Preferred Stock and Stockholders' Equity (Details 4) false false R50.htm 41205 - Disclosure - Convertible Redeemable Preferred Stock and Stockholders' Equity (Details 5) Sheet http://www.BioPharmX.com/role/DisclosureConvertibleRedeemablePreferredStockAndStockholdersEquityDetails5 Convertible Redeemable Preferred Stock and Stockholders' Equity (Details 5) false false R51.htm 41301 - Disclosure - Stock-Based Compensation (Details) Sheet http://www.BioPharmX.com/role/DisclosureStockBasedCompensationDetails Stock-Based Compensation (Details) false false R52.htm 41302 - Disclosure - Stock-Based Compensation (Details 2) Sheet http://www.BioPharmX.com/role/DisclosureStockBasedCompensationDetails2 Stock-Based Compensation (Details 2) false false R53.htm 41401 - Disclosure - Employee Benefit Plan ( Details) Sheet http://www.BioPharmX.com/role/DisclosureEmployeeBenefitPlanDetails Employee Benefit Plan ( Details) false false R54.htm 41501 - Disclosure - Income Taxes (Details) Sheet http://www.BioPharmX.com/role/DisclosureIncomeTaxesDetails Income Taxes (Details) false false R55.htm 41601 - Disclosure - Subsequent Events (Details) Sheet http://www.BioPharmX.com/role/DisclosureSubsequentEventsDetails Subsequent Events (Details) false false All Reports Book All Reports Element us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued had a mix of decimals attribute values: -3 0. Element us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 had a mix of decimals attribute values: 0 2. Element us-gaap_DueToRelatedPartiesCurrent had a mix of decimals attribute values: -3 0. Element us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate had a mix of decimals attribute values: 3 4. 'Monetary' elements on report '00100 - Statement - Consolidated Balance Sheets' had a mix of different decimal attribute values. 'Monetary' elements on report '00300 - Statement - Consolidated Statements of Convertible Redeemable Preferred Stock and Stockholders' Deficit' had a mix of different decimal attribute values. Columns in Cash Flows statement 'Consolidated Statements of Cash Flows (USD $)' have maximum duration 364 days and at least 31 values. Shorter duration columns must have at least one fourth (7) as many values. Column '3/27/2013 - 3/27/2013' is shorter (0 days) and has only 1 values, so it is being removed. 'Monetary' elements on report '40201 - Disclosure - Summary Of Significant Accounting Policies (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '40301 - Disclosure - Going Concern Considerations and Management's Plan (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '41201 - Disclosure - Convertible Redeemable Preferred Stock and Stockholders' Equity (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '41501 - Disclosure - Income Taxes (Details)' had a mix of different decimal attribute values. Process Flow-Through: 00100 - Statement - Consolidated Balance Sheets Process Flow-Through: Removing column 'Dec. 31, 2012' Process Flow-Through: 00105 - Statement - Consolidated Balance Sheets (Parenthetical) Process Flow-Through: 00200 - Statement - Consolidated Statements of Operations and Comprehensive Loss Process Flow-Through: 00400 - Statement - Consolidated Statements of Cash Flows bpmx-20141231.xml bpmx-20141231.xsd bpmx-20141231_cal.xml bpmx-20141231_def.xml bpmx-20141231_lab.xml bpmx-20141231_pre.xml true true